Literature DB >> 17872566

What is the role of iFOBT in screening for colorectal cancer?

David F Ransohoff1.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17872566      PMCID： PMC2000262          DOI： 10.1136/gut.2007.124107

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  16 in total

1.  Screening for colorectal cancer: recommendation and rationale.

Authors: 
Journal:  Ann Intern Med       Date:  2002-07-16       Impact factor: 25.391

Review 2.  Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the U.S. Preventive Services Task Force.

Authors:  Michael Pignone; Somnath Saha; Tom Hoerger; Jeanne Mandelblatt
Journal:  Ann Intern Med       Date:  2002-07-16       Impact factor: 25.391

3.  Colorectal cancer screening: clinical guidelines and rationale.

Authors:  S J Winawer; R H Fletcher; L Miller; F Godlee; M H Stolar; C D Mulrow; S H Woolf; S N Glick; T G Ganiats; J H Bond; L Rosen; J G Zapka; S J Olsen; F M Giardiello; J E Sisk; R Van Antwerp; C Brown-Davis; D A Marciniak; R J Mayer
Journal:  Gastroenterology       Date:  1997-02       Impact factor: 22.682

4.  American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. Also: update 2001--testing for early lung cancer detection.

Authors:  R A Smith; A C von Eschenbach; R Wender; B Levin; T Byers; D Rothenberger; D Brooks; W Creasman; C Cohen; C Runowicz; D Saslow; V Cokkinides; H Eyre
Journal:  CA Cancer J Clin       Date:  2001 Jan-Feb       Impact factor: 508.702

5.  Evaluation of a card collection-based faecal immunochemical test in screening for colorectal cancer using a two-tier reflex approach.

Authors:  Callum G Fraser; Catriona M Mathew; N Ashley G Mowat; John A Wilson; Francis A Carey; Robert J C Steele
Journal:  Gut       Date:  2007-02-19       Impact factor: 23.059

6.  Randomised controlled trial of faecal-occult-blood screening for colorectal cancer.

Authors:  J D Hardcastle; J O Chamberlain; M H Robinson; S M Moss; S S Amar; T W Balfour; P D James; C M Mangham
Journal:  Lancet       Date:  1996-11-30       Impact factor: 79.321

7.  Randomised study of screening for colorectal cancer with faecal-occult-blood test.

Authors:  O Kronborg; C Fenger; J Olsen; O D Jørgensen; O Søndergaard
Journal:  Lancet       Date:  1996-11-30       Impact factor: 79.321

8.  Accuracy of fecal occult blood screening for colorectal neoplasia. A prospective study using Hemoccult and HemoQuant tests.

Authors:  D A Ahlquist; H S Wieand; C G Moertel; D B McGill; C L Loprinzi; M J O'Connell; J A Mailliard; J B Gerstner; K Pandya; R D Ellefson
Journal:  JAMA       Date:  1993-03-10       Impact factor: 56.272

9.  Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence.

Authors:  Sidney Winawer; Robert Fletcher; Douglas Rex; John Bond; Randall Burt; Joseph Ferrucci; Theodore Ganiats; Theodore Levin; Steven Woolf; David Johnson; Lynne Kirk; Scott Litin; Clifford Simmang
Journal:  Gastroenterology       Date:  2003-02       Impact factor: 22.682

10.  Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study.

Authors:  J S Mandel; J H Bond; T R Church; D C Snover; G M Bradley; L M Schuman; F Ederer
Journal:  N Engl J Med       Date:  1993-05-13       Impact factor: 91.245
View more
  4 in total

1.  Nonsteroidal Anti-Inflammatory Drug-Induced Colopathy in a Colorectal Cancer Screening Program.

Authors:  Sanja Borozan; Ljiljana Vuckovic; Brigita Smolovic
Journal:  Med Princ Pract       Date:  2018-10-25       Impact factor: 1.927

2.  Patients' perceptions of colorectal cancer screening tests and preparatory education in federally qualified health centers.

Authors:  Clement K Gwede; Alexis M Koskan; Gwendolyn P Quinn; Stacy N Davis; Jamila Ealey; Rania Abdulla; Susan T Vadaparampil; Gloria Elliott; Diana Lopez; David Shibata; Richard G Roetzheim; Cathy D Meade
Journal:  J Cancer Educ       Date:  2015-06       Impact factor: 2.037

3.  The best protection is early detection: Fostering timely and accurate screening.

Authors:  Aila Akosua Kattner
Journal:  Biomed J       Date:  2022-01-15       Impact factor: 7.892

4.  The Value of Multi-targeted Fecal DNA Methylation Detection for Colorectal Cancer Screening in a Chinese Population.

Authors:  Heiying Jin; Jun Wang; Chunxia Zhang
Journal:  J Cancer       Date:  2021-01-15       Impact factor: 4.478
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.